Tech Company Financing Transactions
Intrexon Funding Round
On 5/8/2008, Intrexon secured $25 million in Series C investment from Third Security.
Transaction Overview
Company Name
Announced On
5/8/2008
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series C
Investors
Proceeds Purpose
According to Intrexon CEO Robert Beech, "The encouraging results from our ongoing clinical and pre-clinical studies have established the basis for expanding our R&D activities toward other disease areas and industry relationships. We greatly appreciate this level of support and commitment from our investors."
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
20358 Seneca Meadows Pkwy. 1400
Blacksburg, MD 20876
USA
Blacksburg, MD 20876
USA
Phone
Website
Email Address
Overview
Intrexon applies engineering principles to biology to enable products in the health, food, energy, consumer and environmental industries.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Randal Kirk
Chief Financial Officer
Rick Sterling
Chief Operating Officer
Thomas Bostick
Chief Scientific Officer
Thomas Reed
VP - Bus. Development
Nir Nimrodi
VP - Finance
Joel Liffmann
VP - General Counsel
Don Lehr
VP - Regulatory Affairs
Jeffrey Perez
Browse more venture capital transactions:
Prev: 5/8/2008: ACT Biotech venture capital transaction
Next: 5/8/2008: iSekurity venture capital transaction
Share this article
News on VC Transactions
We do our best to record every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs